New COPE retraction guidelines address paper mills, third parties, and more

Be-Art/iStock

New retraction guidelines from the Committee on Publication Ethics include more specific details about when to retract a paper, many of which address paper mill activity. For instance, journals should retract articles when “authorship of the publication cannot be verified or there are serious concerns about accountability for the research,” according to the updated guidance, released today. 

COPE also recommends retracting papers with “any form of misrepresentation,” including “deception; fraud (eg, a paper mill); identity theft or fictitious authorship; or undisclosed involvement of artificial intelligence (AI).” 

The organization has also released a new, separate guidance for expressions of concern. Both documents reiterate the as-soon-as-possible timeframe for notices and give more specific details on what information should be included in each type of notice.

Continue reading New COPE retraction guidelines address paper mills, third parties, and more

Guest post: In the name of Scopus, one hijacked journal easily tricks authors

Mahmood Anwar

Editor’s note: Mahmood Anwar is a former business management professor of the National Research University in Tashkent, Uzbekistan. In the course of his research, he keeps an eye out for flawed articles, he told Retraction Watch. He currently mentors 10 to 15 researchers who found him through his YouTube channel, where he discusses research ethics and explains study methods. In his own research, Anwar has covered topics such as feminism in the New Testament and smartphone use and short term memory. Anwar is also on the editorial board for Emerald Publishing’s VILAKSHAN – XIMB Journal of Management and International Journal of Management, Economics & Social Sciences. (Neither journal is indexed in Clarivate’s Web of Science.) 

Aside from his research activities, Anwar also founded “Drive in Malaysia,” the country’s “First-ever Traffic Rules & Test Site,” according to the website. In addition to providing road safety education, the company has an independent review board. Anwar says the IRB was formed to approve research internally among the five members of the IRB committee, and most of the studies they review cover social sciences and road safety. 

Continue reading Guest post: In the name of Scopus, one hijacked journal easily tricks authors

‘Tin Man Syndrome,’ five other case studies retracted following Retraction Watch coverage

A comparison of the images and an overlay, provided by a sleuth.

A journal has retracted a study on ‘Tin Man Syndrome’ plagiarized from a decade-old April Fools’ joke —  which the author now admits was fake.

On August 15, we wrote about a “rare case report” published in Medicine in which authors claimed they had encountered a case of “ectopia cordis interna” and described an asymptomatic man with his heart located in his abdomen. Sleuths believed the case report plagiarized images from a 2015 satirical paper describing a condition of the same name. 

A week later on August 22, Medicine, published by Wolters Kluwer, retracted the paper and five others — all published this year — with shared authors. None of the papers have been cited, according to Clarivate’s Web of Science. 

The retracted papers are:

Continue reading ‘Tin Man Syndrome,’ five other case studies retracted following Retraction Watch coverage

Papers continue to face retractions for failure to license pricy tool 

Donald Morisky

Two journals have retracted papers this year for unauthorized use of a controversial scale whose creator has been known to license use of the questionnaire for six-figure sums – and to aggressively pursue those payments from researchers he claims have misused the instrument without prior approval.  

The Morisky Medication Adherence Scale (MMAS) is named for its creator, Donald Morisky,  now a professor emeritus in community health at UCLA. As the name implies, the measure allows researchers to assess patients’ adherence to drug regimens.

Morisky made a business out of licensing the scale and demanding steep fees for researchers who failed to obtain the proper permissions, as we reported in Science in 2017. Researchers who cannot afford the payments Morisky and his business associate demand have been forced to retract their work.

Continue reading Papers continue to face retractions for failure to license pricy tool